Tag: David Holtzman September 28, 2026 Blocking immune cells’ path into brain limits neurodegenerationMouse study suggests new approach to preventing brain cell death from certain neurological diseases.News Release September 8, 2026 New clues suggest how destructive immune cells wreak havoc in the brainSource: Science September 8, 2026 New clues suggest how destructive immune cells wreak havoc in the brainSource: Science September 8, 2026 Holtzman receives Landis Award for Outstanding MentorshipWashU Medicine neurologist recognized for impact on future scientists.National Leaders September 3, 2026 Key path to Alzheimer’s-like brain damage starts outside the brainStudy finds in mice that immune cells that drive neurodegeneration originate in body’s lymph nodes .News Release August 21, 2026 FDA clears blood test to aid evaluation for Alzheimer’s diseaseBiomarker test is based on technology developed at WashU Medicine.News Release June 24, 2026 Dean’s Medals honor six individuals whose impact advances medicine and improves livesHonorees recognized for extraordinary contributions.National Leaders May 28, 2026 St. Louis researchers receive recognition for groundbreaking Alzheimer’s diagnostic testSource: St. Louis Public Radio May 22, 2026 Bateman and Holtzman receive 2026 American Innovator AwardWashU Medicine neurologists honored for blood-based Alzheimer’s diagnostic test.National Leaders March 5, 2026 Enhanced brain cells clear away dementia-related proteinsNew cellular immunotherapy approach for Alzheimer’s disease shows promise in mice.News Release February 19, 2026 Blood test “clocks” predict when Alzheimer’s symptoms will startEstimating the onset of symptoms could speed development of preventive treatments.News Release May 27, 2025 Sleep aid blocks neurodegeneration in miceLemborexant, similar sleep drugs show promise in treating disorders related to tau, such as Alzheimer’s disease.News Release Posts navigation 1 2 3 … 6 Next ›
